Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Bayer is an innovation company with a more than 150-year history. Our scientific successes are intended to help improve people’s lives.
With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition.
Read more about our economic, ecological and social challenges and opportunities.
This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
We want to create value for our shareholders through innovation, growth and high earning power.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
The Bayer Cross is one of the world′s best-known trademarks
A growing and aging world population requires an adequate supply of food and improved medical care. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose:
The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit, which are also our reporting segments. The corporate functions, Business Services and the service company Currenta support the operational business. In 2018, the Bayer Group comprised 420 consolidated companies in 90 countries throughout the world.
Organization chart with management structure and fields of activity (PDF, 351.8 KB)
The Pharmaceuticals division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu categories.
The Crop Science division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture. The Environmental Science operating unit provides products and services for professional nonagricultural applications, such as vector and pest control and forestry.
The Animal Health business unit ranks among the leading international innovators in its field. It develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.
The corporate functions and Business Services operate as Group-wide competence centers in which business support services are bundled.
Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.
Dual governance system with the following governance bodies:
Board of Management:
seven members, Chairman: Werner Baumann
20 members, Chairman: Werner Wenning
With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving peo-ple’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.
Bayer’s extensive product portfolio contains numerous globally renowned brands.
The Bayer Group comprises 420 consolidated companies** in 90 countries throughout the world. Global headquarters are in Leverkusen, Germany.
** fully consolidated subsidiaries (as of December. 31, 2018)
On December 31, 2018, Bayer employed 116,998 (2017: 99,820) people worldwide. In Germany we had 32,140 (2017: 31,620) employees, which was 27.5% of the total Bayer Group workforce (2017: 31.7%).
figures restated1-6 for definition see footnotes to alternative performance measures Bayer Group (as of Dec. 31, 2018)
Aging Population, big data, prenatal nutrition, water scarcity, animal-human bond: Bayer engages in a conversation about the future that matters the most to you – your own.